Comorbid Cognitive Impairment in Chronic Obstructive Pulmonary Disease (COPD): Current Understanding, Risk Factors, Implications for Clinical Practice, and Suggested Interventions
- PMID: 37109690
- PMCID: PMC10146750
- DOI: 10.3390/medicina59040732
Comorbid Cognitive Impairment in Chronic Obstructive Pulmonary Disease (COPD): Current Understanding, Risk Factors, Implications for Clinical Practice, and Suggested Interventions
Abstract
Cognitive impairment is a common comorbidity in patients with COPD, significantly impacting health and clinical outcomes. Yet it remains under investigated and is largely overlooked. Although the exact cause of cognitive impairment in patients with COPD is still unclear, factors such as hypoxemia, vascular disease, smoking, exacerbation, and physical inactivity have been suggested. While international guidelines recommend identifying comorbidity in patients with COPD, such as cognitive impairment, cognitive assessment is not yet part of the routine assessment. Unidentified cognitive deficits in patients with COPD may have severe impacts on clinical management, resulting in an inability to maintain functional independence, poor self-management, and a greater dropout from pulmonary rehabilitation programs. There is a need to consider cognitive screening as a part of COPD assessment to promote early detection of cognitive impairment. Recognizing cognitive impairment early in the course of the illness allows the development of individualized interventions to meet patients' needs and improve clinical outcomes. Pulmonary rehabilitation should be tailored to cognitively impaired patients with COPD to maximize the benefits and minimize the incompletion rate.
Keywords: COPD; cognition; cognitive impairment; dementia.
Conflict of interest statement
The author declares no conflict of interest.
References
-
- World Health Organization Projections of Mortality and Causes of Death, 2016 to 2060. [(accessed on 21 July 2020)]. Available online: https://www.who.int/healthinfo/global_burden_disease/projections/en/
-
- Santos N.C.D., Miravitlles M., Camelier A.A., Almeida V.D.C., Maciel R.R.B.T., Camelier F.W.R. Prevalence and Impact of Comorbidities in Individuals with Chronic Obstructive Pulmonary Disease: A Systematic Review. Tuberc. Respir. Dis. 2022;85:205–220. doi: 10.4046/trd.2021.0179. - DOI - PMC - PubMed
-
- Vanfleteren L.E.G.W., Spruit M.A., Groenen M., Gaffron S., van Empel V.P.M., Bruijnzeel P.L.B., Rutten E.P.A., Roodt J.O., Wouters E.F.M., Franssen F.M.E. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2013;187:728–735. doi: 10.1164/rccm.201209-1665OC. - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical